Latest News and Press Releases

PharmAla makes shipment to Yale, Agrees with Multidisciplinary Association for Psychedelic Studies to publicly post Investigator's Brochure for LaNeo MDMA

PharmAla warns the public that it does not sell MDMA to consumers, and to be on guard for illegitimate and fake products falsely being sold online.

PharmAla launches its Phenesafe AI, a custom-made technology stack allowing it to easily discover new MDMA-like molecules

PharmAla releases Q2 financial statements showing increased customer deposits, shipments

PharmAla sidesteps tariff risk and expands clinical operations in the United States by contracting with Sharp Clinical Services as distribution partner

PharmAla completes shipment of MDMA to University of Washington, to be used in a Narcissism clinical trial. It also appoints Ali Taghva as CCO.

PharmAla opens the European Market for MDMA, signs Duchefa Farma as its first national-level distributor for LaNeo MDMA in Europe

PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial

PharmAla to supply the STRONG STAR Consortium with new 20mg MDMA dose to treat active-duty military personnel in a clinical trial

PharmAla adds Matthew Azrieli to Advisory Team